Health Care: Drugs

Pfizer Inc (PFE: NYSE)

$28.96 -0.29 | -0.99%
05/17/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 58.99B 67.42B 67.81B 50.01B
Cost of Sales 8.90B 11.64B 13.20B 7.01B
Gross Operating Profit 50.09B 55.78B 54.61B 43.00B
Selling, General, and Administrative Expenses 16.62B 19.47B 19.61B 14.88B
Research & Development 7.87B 9.11B 9.41B 7.91B
Operating Income before D & A (EBITDA) 25.60B 27.20B 25.59B 20.21B
Depreciation & Amortization 7.61B 9.03B 8.49B 4.76B
Interest Income 383.00M 458.00M 402.00M 746.00M
Other Income - Net 0.00 -1.26B -3.07B 195.00M
Special Income / Charges -2.89B 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 13.60B 14.44B 11.22B 12.06B
Interest Expense 1.52B 1.68B 1.80B 1.23B
Pre-Tax Income 12.08B 12.76B 9.42B 10.83B
Income Taxes 2.56B 4.02B 1.12B 2.20B
Minority Interest 28.00M 42.00M 32.00M 9.00M
Net Income From Continuing Operations 9.52B 8.74B 8.30B 8.63B
Net Income From Discontinued Operations 5.08B 1.31B -9.00M 14.00M
Net Income From Total Operations 14.60B 10.05B 8.29B 8.64B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 14.57B 10.01B 8.26B 8.64B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
14.29B 11.67B 11.51B 12.97B
Preferred Dividends
Net Income Available To Common 9.52B 8.74B 8.30B 8.63B
Basic EPS from Continuing Ops. 1.27 1.11 1.03 1.23
Basic EPS from Discontinued Ops. 0.68 0.17 0.00 0.00
Basic EPS from Total Operations 1.95 1.28 1.03 1.23
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.01 0.00 0.00 0.00
Basic EPS, Total 1.96 1.28 1.03 1.23
Basic Normalized Net Income/Share 1.91 1.48 1.43 1.85
EPS fr Continuing Ops. 1.26 1.11 1.02 1.23
EPS fr Discontinued Ops 0.68 0.17 0.00 0.00
EPS fr Total Ops. 1.94 1.28 1.02 1.23
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.01 0.00 0.00
EPS, Total 1.94 1.27 1.02 1.23
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.89 1.48 1.42 1.85
Dividends Paid per Share 0.88 0.80 0.72 0.80

Portfolios with PFE

Latest PFE Headlines from TheStreet

More Financial News for PFE

Press Releases for PFE

See All Press Releases

Partner Headlines for PFE

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter